YM BioSciences Inc. (YMI,YM.TO: Quote) announced the pricing of 35 million common shares at US$2.00 per common share in its previously announced underwritten public offering.
BofA Merrill Lynch is acting as sole book-running manager for the Offering and Wells Fargo Securities, LLC is acting as lead manager. JMP Securities LLC, Collin Stewart LLC, Rodman & Renshaw, LLC and Roth Capital Partners, LLC are acting as co-managers for the Offering.
In addition, the company granted to the underwriters a 30-day option to purchase an additional 5.25 million common shares. The offering is expected to close on or about February 29, 2012, subject to customary closing conditions.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org